Streetbeat News

NEPT

Neptune Wellness Solutions Inc

http://neptunecorp.com/

CEO

Michael Cammarata

Employees

74

Industry

Pharmaceutical Preparation Manufacturing

vision: provide great products and solutions that deliver optimal health and wellness. mission: leverage our scientific and innovative expertise to create and provide our customers globally with the best nutritional products and wellness solutions. neptune is active in five main areas: cannabis business: neptune is working to develop unique extracts and formulations in the legal cannabis wellness field. ingredients: leveraging our global network of suppliers, we source a variety of marine oils, seed oils and specialty ingredients. turnkey solutions: we develop product concepts in collaboration with our customers (branded marketers) as turnkey finished supplements that are ready for sale under their brand, primarily as softgels, capsules, liquids and powders. through our global network of suppliers, we source ingredients and formulate the ideal product. the ingredients are sent to third-party manufacturers, where the formula is developed in a liquid, powder or capsule form and then pack

Open

0.25

Mkt cap

N/A

Volume

2.2M

High

0.27

P/E Ratio

-0.00

52-wk high

28.00

Low

0.19

Div yield

N/A

52-wk low

0.19

The cannabis sector experienced a bullish trend on November 30, 2023, with several companies seeing significant gains in their share prices. Corbus Pharmaceuticals, Neptune Wellness Solutions, and Eastside Distilling were among the top gainers, while CNBX Pharmaceuticals, CLS Holdings USA, and Blueberries Medical were the biggest losers. The article lists the closing prices and percentage changes for both gainers and losers in the cannabis space.

Portfolio Pulse from Benzinga Insights

November 30, 2023 | 9:30 pm

The cannabis sector experienced significant movement on November 29, 2023, with a majority of listed companies showing gains. Notable gainers included Target Group, CNBX Pharmaceuticals, and 22nd Century Group, with increases of 84.14%, 63.64%, and 39.72% respectively. On the downside, AusCann Group Holdings, Item 9 Labs, and Pharmadrug saw their shares decline by 46.67%, 31.43%, and 21.58%. The movements reflect bullish sentiment in the cannabis space.

Portfolio Pulse from Benzinga Insights

November 29, 2023 | 9:30 pm

Neptune Wellness Solutions Inc. (NASDAQ:NEPT) has announced that its subsidiary, Biodroga Nutraceuticals Inc., has secured an accounts receivable factoring facility with Alterna Capital Solutions, LLC. The facility starts at $3 million and can be increased to $8 million. It carries a minimum interest rate of 9.5% per annum and is secured by Biodroga's accounts receivable and inventory. The agreement is for 12 months starting November 8, 2023, with automatic renewal, and Neptune has provided a commercial guaranty.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 1:36 pm

On November 23, 2023, several marijuana stocks experienced significant price movements. Notable gainers included GrowLife with a 19900.00% increase, and 1933 Industries with a 25.00% rise. Corbus Pharmaceuticals, GrowGeneration, and Village Farms Intl also saw gains. Conversely, EVIO led the losers with a 50.00% drop, followed by Global Compliance and CordovaCann. Other notable decliners included Auxly Cannabis Group, Emeren Group, and Cara Therapeutics.

Portfolio Pulse from Benzinga Insights

November 23, 2023 | 9:30 pm

Cannabis stocks experienced significant movements on November 22, 2023. GrowLife (PHOT) saw an extraordinary surge, closing up 19900.00%, while EVIO led the losers with a 50.00% decline. Other notable gainers include 1933 Industries (TGIFF), Corbus Pharmaceuticals (CRBP), and GrowGeneration (GRWG). On the losing side, Global Compliance (FUAPF), CordovaCann (LVRLF), and Auxly Cannabis Group (CBWTF) saw substantial drops in their share prices.

Portfolio Pulse from Benzinga Insights

November 22, 2023 | 9:30 pm

Marijuana stocks experienced significant movement on Tuesday, with EVIO and Affinor Growers leading the gains. EVIO's shares soared by 9900.00%, while Affinor Growers' shares increased by 145.22%. Other notable gainers included Item 9 Labs, Indiva, and Body and Mind. Conversely, 1933 Industries led the losers with a 33.64% decline, followed by Rocky Mountain High and RIV Capital. The article also mentions several other companies in both the gainers and losers categories, reflecting a volatile day for cannabis-related stocks.

Portfolio Pulse from Benzinga Insights

November 21, 2023 | 9:30 pm

Symbotic Inc. (NASDAQ:SYM) shares increased by approximately 22% in pre-market trading following the announcement of Q4 sales that surpassed analyst expectations. The company reported sales of $392 million against a consensus estimate of $306.9 million. Despite reporting a quarterly loss of 8 cents per share, this was an improvement from the 10 cents per share loss in the same period last year. Keybanc upgraded Symbotic's price target from $50 to $63. Other stocks also showed significant movement in pre-market trading, with various gainers and losers listed.

Portfolio Pulse from Lisa Levin

November 21, 2023 | 1:05 pm

On November 20, 2023, several marijuana stocks experienced significant price movements. Notable gainers included 1933 Industries, Heritage Cannabis Holding, and Global Hemp Group, with shares rising by 50.69%, 35.74%, and 24.03% respectively. Neptune Wellness Solutions, Corbus Pharmaceuticals, Canopy Growth, and Aurora Cannabis were among the gainers on NASDAQ. Conversely, Craftport Cannabis, GrowLife, and EVIO were the biggest losers, with their shares plummeting by over 99%. Other notable losers included Body and Mind, Leafbuyer Technologies, and Cresco Labs.

Portfolio Pulse from Benzinga Insights

November 20, 2023 | 9:30 pm

Neptune Wellness has announced a letter of intent to acquire Datasys for a potential total consideration of $112 million, causing its shares to trade higher.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 6:07 pm

Cuentas (CUEN) reported a significant increase in revenue, with an 861% surge compared to the previous quarter and a 200% year-over-year growth in cash position. Cardio Diagnostics Holdings (CDIO) announced a major advancement in coronary heart disease detection with its PrecisionCHD test, now published in a reputable medical journal. Neptune Wellness (NEPT) disclosed a letter of intent to acquire Datasys, a data-marketing and AI company, for up to $112 million.

Portfolio Pulse from ryanfaloona@benzinga.com

November 20, 2023 | 1:50 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.